The relationship between serum levels of LOX-1 ligand containing ApoAI as a novel marker of dysfunctional HDL and coronary artery calcification in middle-aged Japanese men

• 資料種別: 記事
• タイトル: The relationship between serum levels of LOX-1 ligand containing ApoAI as a novel marker of dysfunctional HDL and coronary artery calcification in middle-aged Japanese men
• 著者標目: Aya Hirata; Akemi Kakino; Tomonori Okamura; https://orcid.org/0000-0003-0488-0351; Yoko Usami; Yoshiko Fujita; Aya Kadota; https://orcid.org/0000-0001-7378-0544; Akira Fujiyoshi; https://orcid.org/0000-0002-5790-7119; Takashi Hisamatsu; https://orcid.org/0000-0002-6244-1763; Keiko Kondo; https://orcid.org/0000-0002-9709-4474; Hiroyoshi Segawa; Tatsuya Sawamura; https://orcid.org/0000-0002-5415-2080; Katsuyuki Miura; https://orcid.org/0000-0002-2646-9582; Hirotsugu Ueshima; https://orcid.org/0000-0002-7742-4253
• 出版年月日等: 2020-11
• 出版年（W3CDTF）: 2020-11
• タイトル（掲載誌）: Atherosclerosis
• 巻号年月日等（掲載誌）: 313
• 掲載巻: 313
• 掲載ページ: 20-25
• 掲載年月日（W3CDTF）: 2020-11
• ISSN（掲載誌）: 00219150
• 出版事項（掲載誌）: Elsevier BV
• 件名標目: Male; Apolipoprotein A-I; Coronary Artery Disease; Middle Aged; Ligands; Scavenger Receptors, Class E; Coronary Vessels; Japan; Risk Factors; Humans; Lipoproteins, HDL; Vascular Calcification; Aged
• 対象利用者: 一般
• 標準番号（その他）: PMID : 33011550
• DOI: 10.1016/j.atherosclerosis.2020.09.013
• 作成日（W3CDTF）: 2020-09-23
• 著作権情報: https://www.elsevier.com/tdm/userlicense/1.0/
• 関連情報（URI）: https://api.elsevier.com/content/article/PII:S0021915020305323?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0021915020305323?httpAccept=text/plain
• 参照: Serum modified high-density lipoprotein and risk of atherosclerotic cardiovascular disease in a Japanese community-based nested case–control study; https://cir.nii.ac.jp/crid/1360857593783640960; Coronary Artery Calcium in Assessment of Atherosclerotic Cardiovascular Disease Risk and its Role in Primary Prevention; https://cir.nii.ac.jp/crid/1390016184232273024; Relationship between Serum Proprotein Convertase Subtilisin/Kexin Type 9 Concentration and Prevalence of Coronary Artery Calcium in a Community-Based Sample of Japanese Men; https://cir.nii.ac.jp/crid/1390859616450177024
• 参照: Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein; https://cir.nii.ac.jp/crid/1360002218673266560; Serum level of LOX-1 ligand containing ApoB is associated with increased carotid intima-media thickness in Japanese community-dwelling men, especially those with hypercholesterolemiaLOX-1 ligand and IMT in Japanese; https://cir.nii.ac.jp/crid/1360004232229720704; Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies; https://cir.nii.ac.jp/crid/1360011144051294720; Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease; https://cir.nii.ac.jp/crid/1360011144120943360; Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population; https://cir.nii.ac.jp/crid/1360283690791145600; Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study; https://cir.nii.ac.jp/crid/1360285706965303168; Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge; https://cir.nii.ac.jp/crid/1360292619301640960; Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease; https://cir.nii.ac.jp/crid/1360292619539944704; Effects of Torcetrapib in Patients at High Risk for Coronary Events; https://cir.nii.ac.jp/crid/1360292620095260928; Comparison of Coronary Artery Calcium Presence, Carotid Plaque Presence, and Carotid Intima-Media Thickness for Cardiovascular Disease Prediction in the Multi-Ethnic Study of Atherosclerosis; https://cir.nii.ac.jp/crid/1360292621553043456; Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy–Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices; https://cir.nii.ac.jp/crid/1360292621577746688; Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis; https://cir.nii.ac.jp/crid/1360567186387136000; HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events; https://cir.nii.ac.jp/crid/1360574094941567616; Quantification of coronary artery calcium using ultrafast computed tomography; https://cir.nii.ac.jp/crid/1360855568725675904; High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.; https://cir.nii.ac.jp/crid/1360855570756511360; Modifying Apolipoprotein A-I by Malondialdehyde, but Not by an Array of Other Reactive Carbonyls, Blocks Cholesterol Efflux by the ABCA1 Pathway; https://cir.nii.ac.jp/crid/1361137043415857408; Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients; https://cir.nii.ac.jp/crid/1361137044292346496; HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms; https://cir.nii.ac.jp/crid/1361137044373826560; Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality; https://cir.nii.ac.jp/crid/1361137045938369024; HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study; https://cir.nii.ac.jp/crid/1361418518582153472; Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH–JAPAN study; https://cir.nii.ac.jp/crid/1361699993649478400; Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease; https://cir.nii.ac.jp/crid/1361981470321961344; Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study; https://cir.nii.ac.jp/crid/1361981471410819456; NF- activation in endothelial cells treated with oxidized high-density lipoprotein; https://cir.nii.ac.jp/crid/1362544420992941056; Less Subclinical Atherosclerosis in Japanese Men in Japan than in White Men in the United States in the Post-World War II Birth Cohort; https://cir.nii.ac.jp/crid/1362544421001174656; International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values; https://cir.nii.ac.jp/crid/1362544421352801920; Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths; https://cir.nii.ac.jp/crid/1362825895306900736; Relation Between Serum Total Cholesterol Level and Cardiovascular Disease Stratified by Sex and Age Group: A Pooled Analysis of 65 594 Individuals From 10 Cohort Studies in Japan; https://cir.nii.ac.jp/crid/1363107369370660736; General Cardiovascular Risk Profile for Use in Primary Care; https://cir.nii.ac.jp/crid/1363107370956371840; Comparison of Coronary Artery Calcium Scores Between Electron Beam Computed Tomography and 64-Multidetector Computed Tomographic Scanner; https://cir.nii.ac.jp/crid/1363388843912430208; Modified HDL: Biological and physiopathological consequences; https://cir.nii.ac.jp/crid/1363388844191620096; Long-Term Prognosis Associated With Coronary Calcification; https://cir.nii.ac.jp/crid/1363951793652475776; High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions; https://cir.nii.ac.jp/crid/1364233269073160960; LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL management; https://cir.nii.ac.jp/crid/1364233269644454656; 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines; https://cir.nii.ac.jp/crid/1370572092612845569; Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells; https://cir.nii.ac.jp/crid/1370572092612845708; Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study; https://cir.nii.ac.jp/crid/1390001204432080256; Improvement in Japanese Clinical Laboratory Measurements of Total Cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network; https://cir.nii.ac.jp/crid/1390282679409467648; Coronary Artery Calcification by Computed Tomography in Epidemiologic Research and Cardiovascular Disease Prevention; https://cir.nii.ac.jp/crid/1390282679452217344; A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL; https://cir.nii.ac.jp/crid/1390282752357595648; Committee for Epidemiology and Clinical Management of Atherosclerosis. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017; https://cir.nii.ac.jp/crid/1390845712993521792
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org; 科学研究費助成事業データベース; https://kaken.nii.ac.jp/ja

• 要約等: Dysfunctional high-density lipoprotein (HDL) is a risk factor for cardiovascular disease (CVD) beyond HDL concentrations. Recently, a novel method has...